RTCT raises hard questions about sponsor liability, blinding integrity, DSMB overlap, and AI accountability that the industry hasn’t yet resolved. Both sides of that ledger deserve honest consideration.
- Pharma's Digital Transformation: Where It's Really At
- How AI Is Changing Clinical Trial Design, Not Just Speed
- What Is Clinical Trials Day? Why Technology Helps Research Rise
- DiMe's Navigator: Why Teams Still Stall On Digital Endpoints
- Why Are Life Science Companies So Poorly Prepared For RIM's Future?
- Digital Endpoints Are Ready. Clinical Development Isn't
- Why Clinical Trial Data Cleaning Must Go Continuous (And How To Do It)
- What Clinical Analytics Solutions Are Shaping Clinical Research
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
A Leading Academic Medical Center Monitors Newly Diagnosed Myeloma Patients
Learn how eCOA helped to motivate patients and increased engagement around experiences outside of the clinical setting, which otherwise may have gone unmentioned.
-
Transforming Field Rep Success
As the healthcare landscape evolves, maintaining accurate and timely information delivery becomes vital for building strong HCP relationships and improving patient outcomes.
-
Bridging The Knowledge Gap On Digital Clinical Measures: A Technology Partner's Perspective On The 'The Playbook'
ActiGraph CEO, Jeremy Wyatt, shares his perspectives on The Playbook, the essential guide for remote patient monitoring in clinical research, clinical care and public health, compiled by the Digital Medicine Society (DiMe).
-
Opportunities For Enhancing Signal Detection In Schizophrenia Trials
Signal detection in schizophrenia trials is hindered by increased placebo response, complex rating scales, inconsistent rater performance, and data quality issues.
-
Come To The Dark (Mode) Side
Many of the decisions made by a product team start as suggestions from a user community of clinical professionals. While planning the development of a recently launched CTMS, a focus group was led where clinical professionals weighed in on potential improvements for a new system.
-
Exploring The Potential Of Non-Consumer Smartphones In Clinical Trials
We selected and evaluated a non-consumer device, to explore its potential as a reliable tool for home-based ePRO measure administration. Here’s what we learned from this usability testing.
-
10 Questions To Ask When Looking For An eClinical Platform
Stakeholders should ask these questions when aiming to enhance the integrity and efficiency of their clinical trials while minimizing risks associated with inadequate eClinical solutions.
-
More Than Document Collection: The eTMF As The Conductor Of Study Start-Up Part 1 – Site ID And Selection
In this post, gain insight into how the eTMF can mitigate the main drivers of delay in the site ID and Selection process.
-
How EDC Software Improves Patient Safety
As clinical research evolves, EDC remains a cornerstone for data accuracy, ethical compliance, and faster access to effective treatments.
-
Fulfilling MDR Requirements For A Groundbreaking Microsurgery Robot
Discover the help a company pioneering the field of open surgery received to advance their robotic technology, replacing their former EDC system to improve their clinical research efficiency.
RECENT NEWSLETTERS
- 05.21.26 -- AI, HEOR, And Hidden Costs Reshaping Clinical Trials
- 05.14.26 -- AI, RWE, And The Systems Breaking Clinical Trials
- 05.07.26 -- How AI, ICH E6(R3) & RWD Are Reshaping Clinical Trials
- 05.02.26 -- Best Of April: AI In Clinical Trials — What Working
- 04.30.26 -- AI, RWE & Predictive Analytics Are Reshaping Trials